BioSpace News Archive

One way to keep people healthier and reduce healthcare costs is to identify patients at risk for hospital readmissions.

Cassiopea SpA (SIX: SKIN), a specialty pharmaceutical company developing and commercializing prescription drugs with novel mechanisms of action (MOA) to address long-standing and essential dermatological conditions, announced today that it has submitted a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) seeking marketing approval for clascoterone cream 1% for the treatment of acne.

August 20th, 2019, Novalis LifeSciences, an investment and advisory firm for the Life Science industry, announced today that it has raised $85M in capital for its first fund - Novalis LifeSciences Investments I, L.P.

AQUALUNG THERAPEUTICS CORPORATION receives a $225,000 National Institutes of Health (NIH) (award number R41 HL147769-01) Grant to establish a novel panel of Acute Respiratory Distress Syndrome (ARDS) biomarkers (CRIT-ICU Panel) that stratifies subjects at risk for ARDS into high and low mortality sub-groups.

Heron Therapeutics, Inc. (Nasdaq: HRTX), today announced that the results from EPOCH 2, a Phase 3 study of the investigational agent HTX-011 in open inguinal hernia repair surgery with mesh, have been published in the journal, Hernia, in an article entitled “HTX-011 reduced pain intensity and opioid consumption versus bupivacaine HCl in herniorrhaphy: results from the phase 3 EPOCH 2 study.”

NorthStar Medical Radioisotopes, LLC and Purdue University’s College of Pharmacy today announced a collaborative agreement which expands the College of Pharmacy’s nuclear pharmacy training program

Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC notifies investors that a class action lawsuit has been filed against Teva Pharmaceutical Industries Ltd. and certain of its officers, on behalf of shareholders who purchased or otherwise acquired Teva American Depositary Shares between August 4, 2017 and May 10, 2019, inclusive.

Physical therapy and musculoskeletal care experts join SWORD Health in the wake of the company’s most recent study, that corroborates the clinical validity of SWORD Digital Therapist

Alligator Bioscience (Nasdaq Stockholm: ATORX), today announces that a license agreement has been reached with Biotheus Inc. (“Biotheus”), a privately held Chinese company based in Zhuhai, Guangdong, China.

Actify, a leader in innovative mental health treatment, is proud to support veteran care with the launch of Transcranial Magnetic Stimulation (TMS) in the State of Maryland.